An observational study in Deep Vein Thrombosis (DVT), sponsored by Dr. Kerstin de Wit. Completed at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-05-15.
Sponsored by Dr. Kerstin de Wit · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 106 studies in Venous Thrombosis with a site in Canada — 5 open to participants now, 8 under way, 3 of them phase 3. Venous Thrombosis · Canada.
Among the 106 studies in Venous Thrombosis with a site in Canada, this one is the 13th largest by enrollment of the 27 observational ones that give a count, is one of 2 that started in 2024, is one of 27 observational ones, and was the 101st registered.
785 studies on the registry are indexed under Venous Thrombosis; 110 are open to participants now.
Browse Venous Thrombosis studies →5 of the 106 studies in Venous Thrombosis with a site in Canada are open now. Recruiting first, the newest first:
McMaster University · Sites in Canada
Ages 18–35 · Women only · Healthy volunteers
University of Calgary · Sites in Canada, Belgium, Denmark and 4 more countries
Ages 18+ · Women only
Ottawa Hospital Research Institute · Sites in Canada
Ages 18+
Sunnybrook Health Sciences Centre · Sites in Canada
Ages 18+
McGill University Health Centre/Research Institute of the McGill University Health Centre · Sites in Canada
Ages 18+
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 84 Venous Thrombosis studies recruiting now, 59 (70%) set no upper age limit and 9 (11%) stop at 75 or younger; 10 take children under 18; 7 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
106 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 14 · Phase 3 40 · Phase 4 8
First in 1994; this study’s year is marked. 2 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 458 is above the median of 301 across 274 observational studies indexed under Venous Thrombosis.
Median enrollment 600 across the 79 interventional studies, 366 across the 27 observational. Of the 85 that completed or were terminated, 24 (28%) have results posted.
This tab as a report to print or save as PDF → With an account.
35 of 106 have an industry lead sponsor. The 10 most frequent:
Dr. Kerstin de Wit is the lead sponsor of 6 studies on the registry; 4 are open to participants now.
Dr. Kerstin de Wit has 1 study filed under Venous Thrombosis — fewer than ten, so there is no comparison to draw.
2 of the studies in Venous Thrombosis with a site in Canada that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03559114Phase 3Sunnybrook Health Sciences CentrePROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST) | 2026-12 |
| NCT07759635McMaster UniversityThe Influence of Plan B® on Cardiovascular Health. | 2027-06-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 106 studies in Venous Thrombosis with a site in Canada, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This observational study will use a new way to test for deep vein thrombosis (DVT) of the leg. A DVT is a blood clot in the leg and is a medical problem that can cause swelling, pain, and redness. If the blood clot is not treated, it can cause more serious, long-term effects, and occasionally lead to death.
The main questions the study aims to answer are:
The study will be run in the emergency department and urgent care centre in Kingston, Ontario. Patients who are tested for a DVT in the leg can be included in the study. Researchers follow the patient through chart review to make sure the new system is safe and efficient.
Study participants will be enrolled after a visit to the Kingston Health Sciences emergency department and urgent care centre in Kingston, Ontario.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
False negative rate of the new DVT testing
This is the proportion of patients who have DVT excluded by the new ToDay protocol and who were subsequently diagnosed with either a lower limb DVT or pulmonary embolism.
Time frame: This will be measured at 30-days after the patient's index emergency department visit.
Efficiency of the new DVT testing
This is the proportion of all study patients who do not require ultrasound imaging at index visit.
Time frame: At the index emergency department visit.
Plan to share: No
No publications or documents are linked to this record.
Ran from Jan 2024 to primary completion in Dec 2024, 11 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Dr. Kerstin de Wit